Partner with Us

The MMRC is a cutting-edge collaborative research model that brings together a network of world-class multiple myeloma research institutions with partners in the biotech and pharmaceutical industries to conduct phase 1 and phase 2 clinical trials of novel compounds and combination therapies for multiple myeloma.

As a trusted third party, our model aims to de-risk multiple myeloma drug development by promoting efficiency, speed, and results through innovative business solutions.

Our track record speaks for itself. To date we have spearheaded the launch of more than 40 clinical trials opening trials conducted through the MMRC an average of 60% faster than comparable oncology clinical trials and consistently beating our timelines for enrollment.

Find out about partnering with the MMRC as one of our member institutions here.

We work with the biotech and pharmaceutical industries to conduct early-stage clinical trials. Learn more.

Learn more about the partnership between MMRC and its key partners here.